Catalyst gets European patent for use of vigabatrin to prevent addiction of opioids in pain management
Monday, July 12, 2010 17:00 IST Coral Gables, Florida
Catalyst Pharmaceutical Partners, Inc announced that the European Patent Office (EPO) granted to Brookhaven Science Associates/Brookhaven National Laboratory (Brookhaven) a European patent for the use of vigabatrin